Skip to main content

Table 1 Demographics of AOSD patients

From: Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still’s disease

Variable

Value

Number

87

Female, n (%)

69 (79.3)

Age at onset (years)

49.3 ± 19.9

Ferritin (ng/mL)

11251.2 ± 16997.9

CRP (mg/dL)

12.4 ± 8.2

ESR (mm(1 h))

71.1 ± 30.1

Liver dysfunction, n (%)

68 (78.1)

MAS, n (%)

23 (26.4)

Initial dose of PSL (mg/day)

41.8 ± 12.2

Steroid pulse, n (%)

55 (63.2)

Immunosuppressant, n (%)

51 (58.6)

Biologics, n (%)

26 (29.8)

Polycyclic systemic type, n (%)

56 (64.3)

Monocyclic systemic type, n (%)

19 (21.8)

Chronic arthritis type, n (%)

12 (13.7)

Relapse, n (%)

40 (45.9)

  1. Mean ± standard deviation or number (percentage) is shown
  2. AOSD adult onset Still’s disease, CRP C-reactive protein, ESR erythrocyte sedimentation rate, MAS macrophage activation syndrome, PSL prednisolone